A detailed history of Aquatic Capital Management LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Aquatic Capital Management LLC holds 64,400 shares of EXAS stock, worth $3.27 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
64,400
Holding current value
$3.27 Million
% of portfolio
0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$41.33 - $74.26 $2.66 Million - $4.78 Million
64,400 New
64,400 $2.72 Million
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $708,720 - $908,640
12,000 Added 181.82%
18,600 $1.38 Million
Q3 2023

Nov 14, 2023

BUY
$65.94 - $99.04 $435,204 - $653,664
6,600 New
6,600 $450,000
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $1.11 Million - $1.71 Million
34,700 Added 377.17%
43,900 $1.43 Million
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $327,612 - $701,316
9,200 New
9,200 $362,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.98B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.